SCHEMBL6779670

SCHEMBL6779670

O=C(/C=C/c1ccccc1F)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.58
MAPT P10636 5/20 0.56
LMNA P02545 2/20 0.56
ALDH1A1 P00352 1/20 0.56
NTSR1 P30989 1/20 0.56
RECQL P46063 1/20 0.56
ALOX5 P09917 2/20 0.55
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
HSP90AA1 P07900 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP1B1 Q16678 1/20 0.50
HPGD P15428 1/20 0.49
ALOX12 P18054 1/20 0.49
ATM Q13315 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MAPK1 P28482 1/20 0.49
MDM4 O15151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12443508 0.83 MAPT (0.69) MAOBMAPTLMNAALDH1A1NTSR1
SCHEMBL28865532 0.80 MAOB (0.70) MAOBMAPTLMNAALDH1A1NTSR1
SCHEMBL3733057 0.79 MAOB (0.62) MAOBMAPTLMNAALDH1A1NTSR1
SCHEMBL8878372 0.79 MAOB (0.69) MAOBMAPTLMNAALDH1A1NTSR1
SCHEMBL8987422 0.79 MAOB (0.69) MAOBMAPTLMNAALDH1A1NTSR1
SCHEMBL29716572 0.79 MAOB (0.69) MAOBMAPTLMNAALDH1A1NTSR1
SCHEMBL11580338 0.78 CYP1B1 (0.68) MAOBMAPTLMNAALDH1A1RECQL
SCHEMBL11578509 0.78 CYP1B1 (0.68) MAOBMAPTLMNAALDH1A1RECQL
SCHEMBL11346079 0.78 ABCG2 (0.69) MAOBMAPTLMNAALDH1A1NTSR1
SCHEMBL11346080 0.78 ABCG2 (0.69) MAOBMAPTLMNAALDH1A1NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6703387-B2 STYRYLBENZODIAZEPINES HOFFMANN-LA ROCHE INC. 2004-03-09 US disclosed
EP-1299364-A1 BENZODIAZEPINES AS INHIBITORS OF HPV E1 HELICASE F. HOFFMANN-LA ROCHE AG (CH) 2003-04-09 EP disclosed
US-20020128262-A1 Inhibitors of HPV E1 helicase enzyme F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2002-09-12 US disclosed
WO-2002000632-A1 BENZODIAZEPINES AS INHIBITORS OF HPV E1 HELICASE F. HOFFMANN-LA ROCHE AG (CH) 2002-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128262-A1 Inhibitors of HPV E1 helicase enzyme DHX15, DHX35, DHX36 MAOB 1374/4885MAPT 3880/4885LMNA 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.